Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine
Status:
Completed
Trial end date:
2020-05-13
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether the application of glutamine versus control in
patients with high risk for AKI identified by biomarkers can reduce kidney damage after
cardiac surgery.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Muenster
Collaborators:
Fresenius Kabi IZKF (Interdisciplinary Centre for Clinical Research (IZKF), Muenster)